Open Health: The proposed total amount of GCP research project cooperation funds to be invested in batches to Sichuan Academy of Medical Sciences and Sichuan People's Hospital is not less than 80 million yuan.

KaiNeng Health announced that the company has decided to sign a "Letter of Intent for Cooperation" with its subsidiary Shanghai Origin Biotechnology Co., Ltd. and Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital. During the cooperation period from 2026 to 2030, the company will invest a total amount of not less than 80 million yuan in batches into GCP research projects in the fields of orthopedics, ophthalmology, and aging-related diseases, and carry out multiple GCP and IIT research projects on stem cell and immune cell preparations.